Experts think monoclonal antibodies could be best option for COVID-19 treatment

The Washington Post (9/30, A1, Johnson) reports many experts think a drug, called a monoclonal antibody cocktail, “could be the best bet to defang the novel coronavirus and transform it from a potentially lethal infection into a treatable illness.” NIH Director Francis Collins said it is “a real best chance of being a game changer.” Meanwhile, Janet Woodcock, who is leading therapeutics development for Operation Warp Speed, said, “We’re looking for big impacts on disease, not the small incremental impacts we often see in ordinary drug development.” However, the article adds, “Unlike conventional pills, these are expensive, injectable drugs synthesized by living organisms in specialized reactors, at a biological cadence that can’t be rushed.”